Gujarat Terce Laboratories Ltd

Healthcare · Pharmaceuticals & Biotechnology

BSE: 524314

₹34.83

Oct. 5, 2026 · BSE · bse_bhavcopy

Peers in Pharmaceuticals & Biotechnology

The largest companies in the same industry by market cap. This company ranks #162 of 184. PE, ROE, 1Y return and scores come from the daily/weekly precomputed snapshot.

Company	Market cap (₹ Cr)	PE (TTM)	ROE	1Y return	Div. yield	Quality	Valuation	Momentum
Sun Pharmaceutical Industries Limited	427,010	143.5	13.7%	7.6%	—	72	8	30
Divi's Laboratories Limited	244,125	83.0	15.3%	57.8%	0.33%	70	4	51
Torrent Pharmaceuticals Limited	161,506	77.7	12.2%	35.3%	0.80%	56	0	31
Zydus Lifesciences Limited	113,616	32.6	17.3%	14.5%	0.09%	74	24	84
Cipla Limited	107,888	35.1	11.2%	-11.7%	0.97%	73	29	62
Laurus Labs Limited	106,505	122.0	17.1%	128.4%	—	78	24	53
Mankind Pharma Limited	102,382	46.9	11.7%	0.9%	—	68	12	86
Dr. Reddy's Laboratories Limited	100,411	150.9	10.9%	-3.7%	—	62	33	71
Gujarat Terce Laboratories Ltd (this stock)	27	12.7	34.5%	-57.9%	—	73	83	31

Valuation multiples

Current only. Market cap is the whole company's; sales/EBITDA are trailing-twelve-month standalone; debt and cash come from the latest filed standalone balance sheet (March 31, 2026). EBITDA = PBT + interest + depreciation.

Enterprise value

₹26 Cr

EV / EBITDA

7.2x

EV / Sales

0.56x

Market cap / Sales

0.59x

Earnings yield

7.87%

Quarterly Financials

Download CSV

Standalone Consolidated

↓ Negative

Quarterly Revenue

Jun 2026 quarterly revenue is Rs 9 Cr, down 13.4% YoY.

Period end	Revenue (₹ Cr)	PBT (₹ Cr)	Net profit (₹ Cr)	Basic EPS
June 30, 2026	9	-0	-0	₹-0.2300
March 31, 2026	11	0	0	₹0.1300
Dec. 31, 2025	12	1	1	₹0.9500
Sept. 30, 2025	13	2	—	₹1.8900
June 30, 2025	11	-0	—	₹-0.0600
March 31, 2025	12	1	—	₹-4.5700
Dec. 31, 2024	13	1	1	₹1.3600
Sept. 30, 2024	13	2	1	₹2.0000
June 30, 2024	12	-0	-0	₹-0.1000
March 31, 2024	12	1	1	₹0.7300
Dec. 31, 2023	13	1	1	₹0.9100
Sept. 30, 2023	12	0	0	₹0.4500
June 30, 2023	11	-1	-1	₹-1.7600

Quarterly income statement (standalone, ₹ Cr)

Indicator	Jun 26	Mar 26	Dec 25	Sep 25	Jun 25	Mar 25	Dec 24	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23	Jun 23
Total income (before exceptional items)	9	11	12	13	11	12	13	13	12	12	13	12	11
Operating revenue	9	11	12	13	11	12	13	13	12	12	13	12	11
Other income	0	0	0	0	0	0	0	0	0	0	0	0	0
Operating expenses	9	11	11	11	11	11	12	12	12	11	12	11	12
Operating profit	-0	1	1	2	-0	1	1	2	0	1	1	1	-1
Operating profit margin	-5.5%	6.5%	9.3%	14.6%	-0.2%	8.5%	8.6%	12.5%	0.7%	8.2%	6.5%	4.5%	-10.5%
Depreciation	0	0	0	0	0	0	0	0	0	0	0	0	0
Interest	0	0	0	0	0	0	0	0	0	0	0	0	0
Exceptional items, gain / (loss)	—	-0	—	—	—	—	—	—	—	—	—	—	—
Profit before tax	-0	0	1	2	-0	1	1	2	-0	1	1	0	-1
Tax	0	0	0	0	-0	4	-0	0	0	0	—	—	—
Net profit	-0	0	1	—	—	—	1	1	-0	1	1	0	-1
EPS	-0.23	0.13	0.95	1.89	-0.06	-4.57	1.36	2.00	-0.10	0.73	0.91	0.45	-1.76
Net profit (TTM)	—	—	—	—	—	—	3	3	1	0	1	-0	-1
EPS (TTM)	2.74	2.91	-1.79	-1.38	-1.27	-1.31	3.99	3.54	1.99	0.33	0.68	—	—

Total income excludes exceptional items, which are shown on their own row. Trendlyne and Screener fold exceptional items into revenue or other income, so their totals differ from this table by exactly that row.

Annual Financials

Annual income statement (standalone, ₹ Cr; CAGR to the latest year)

Indicator	CAGR 3Y	CAGR 5Y	Mar 26	Mar 25	Mar 24	Mar 23	Mar 22	Mar 21	Mar 20	Mar 19	Mar 18	Mar 17
Total income (before exceptional items)	0.5%	13.0%	48^†	51^†	48^†	47^†	40^†	26^†	—	31^†	29^†	—
Operating revenue	0.5%	13.5%	47^†	50^†	48^†	47^†	40^†	25^†	38^†	31^†	29^†	26^†
Other income	—	—	0^†	0^†	0^†	0^†	0^†	1^†	—	0^†	0^†	—
Operating expenses	—	—	44^†	46^†	47^†	49^†	39^†	28^†	37^†	31^†	29^†	25^†
Operating profit	—	—	4^†	4^†	1^†	-2^†	1^†	-3^†	1^†	0^†	0^†	1^†
Operating profit margin	—	—	7.9%^†	7.7%^†	2.6%^†	-4.6%^†	2.8%^†	-11.0%^†	1.8%^†	1.6%^†	1.1%^†	2.9%^†
Depreciation	—	—	0^†	0^†	0^†	0^†	0^†	0^†	0^†	0^†	0^†	0^†
Interest	—	—	0^†	0^†	1^†	1^†	0^†	0^†	0^†	0^†	0^†	0^†
Exceptional items, gain / (loss)	—	—	-0^†	0^†	0^†	0^†	0^†	0^†	0^†	0^†	0^†	0^†
Profit before tax	—	—	3^†	3^†	1^†	-3^†	1^†	-3^†	0^†	0^†	0^†	0^†
Tax	—	—	1^†	4^†	—	—	—	—	—	—	—	—
Net profit	—	—	—	—	0^†	-2^†	1^†	-3^†	0^†	0^†	0^†	-0^†
EPS	—	—	2.91^†	-1.31^†	0.33^†	—	—	—	—	—	—	—

^† Derived: the sum of that fiscal year's four quarterly filings (a real annual filing is used wherever one exists). Checked against filed annual figures, the sum lands within 0.5% for about 94% of company-years.

Annual ratios (standalone)

Ratio	Mar 26	Mar 25	Mar 24	Mar 23	Mar 22	Mar 21	Mar 20	Mar 19	Mar 18	Mar 17
Operating margin	7.9%^†	7.7%^†	2.6%^†	-4.6%^†	2.8%^†	-11.0%^†	1.8%^†	1.6%^†	1.1%^†	2.9%^†
EBIT margin	6.8%^†	7.6%^†	2.5%^†	-4.6%^†	2.9%^†	-8.5%^†	1.9%^†	1.9%^†	1.9%^†	1.3%^†
PBT margin	6.4%^†	6.8%^†	1.1%^†	-6.2%^†	1.9%^†	-10.1%^†	1.2%^†	1.1%^†	1.1%^†	0.1%^†
Net margin	—	—	0.5%^†	-3.6%^†	2.2%^†	-10.0%^†	0.7%^†	1.4%^†	0.9%^†	-1.2%^†
Interest coverage	17.96x^†	9.16x^†	1.80x^†	-3.01x^†	2.86x^†	-5.51x^†	2.50x^†	2.36x^†	2.44x^†	1.07x^†
Dividend payout	—	—	—	—	—	—	—	—	—	—
Earnings retention	—	—	—	—	—	—	—	—	—	—
Current ratio	1.32x	0.95x	—	—	—	—	—	—	—	—
Quick ratio	0.98x	0.66x	—	—	—	—	—	—	—	—
Debt to equity	0.13x	0.15x	—	—	—	—	—	—	—	—
Return on equity	—	—	—	—	—	—	—	—	—	—
Return on assets	—	—	—	—	—	—	—	—	—	—
Return on capital employed	23.7%^†	37.4%^†	—	—	—	—	—	—	—	—
Asset turnover	1.93x^†	2.20x^†	—	—	—	—	—	—	—	—

Margins and asset turnover use operating revenue (interest earned for banks, excluding other income), not total income. Liquidity, leverage and return ratios need a filed standalone balance sheet, which exists only for recent years; returns use year-end equity/assets. Dividend payout is shown only for companies with a dividend record. † = built from a summed fiscal year.

Revenue Mix

Data unavailable.

Cash Flow

Year ended	Operating (₹ Cr)	Investing (₹ Cr)	Financing (₹ Cr)	Capex (₹ Cr)	Free Cash Flow (₹ Cr)
March 31, 2026	2	-0	0	0	2
March 31, 2025	3	0	-3	-0	3

Balance Sheet (standalone)

Year ended	Total Assets (₹ Cr)	Total Equity (₹ Cr)	Reserves (₹ Cr)	Borrowings, Current (₹ Cr)	Borrowings, Non-current (₹ Cr)	Current Assets (₹ Cr)	Current Liabilities (₹ Cr)	Cash & Equivalents (₹ Cr)	Net Block (₹ Cr)	Inventory (₹ Cr)
March 31, 2026	25	10	2	1	0	14	11	3	3	4
March 31, 2025	23	6	-1	1	0	12	13	1	4	4

Financial charts

Trend charts drawn from the standalone income-statement and ratio tables above (oldest year on the left); a gap means that period has no figure. Annual years marked † in the tables are derived from four quarters.